Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

SEC Filing Details

Document Details

Form

Filing Date

Dec 3, 2018

Document Date

Nov 30, 2018

Form Description

Statement of changes in beneficial ownership of securities

Filing Group

3,4,5

Company

Spectrum Pharmaceuticals, Inc.

Issuer

SPECTRUM PHARMACEUTICALS INC

Filer

ASHTON WILLIAM

Filing Formats

View HTML

Download PDF

Download DOC

:

Price:

Change:

Day High:

Day Low:

Volume:

This Web site contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and in reliance upon the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on the beliefs of the Company's management as well as assumptions made by and information currently available to the Company's management. Readers should not put undue reliance on these forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Spectrum Pharmaceuticals, Inc.'s actual results may differ materially from the results projected in the forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in the Company's most recent Form 10-K and 10-Qs. We do not plan to update any such forward-looking statements and expressly disclaim any duty to update the information contained in this filing except as required by law.

SEC Filing Details

Document Details

Filing Formats

:

Our Company

Product Portfolio

Investor Relations

Patient Assistance (STAR)

Medical Professionals

Careers

Contact Us

SEC Filing Details

Document Details

Filing Formats

:

Search IR

Our Company

Product Portfolio

Investor Relations

Patient Assistance (STAR)

Medical Professionals

Careers

Contact Us